Stroke Recovery: Brain Repair Drug Shows Promise
A groundbreaking UCLA study reveals a promising new drug, DDL-920, that mirrors the restorative effects of physical rehabilitation in mice, offering hope for improved stroke recovery. This innovative stroke recovery drug enhances crucial brain rhythms and repairs neural connections damaged by stroke,a leading cause of adult disability. The research team discovered that stroke disrupts essential gamma oscillations, impacting neural networks vital for movement, and DDL-920 effectively stimulates these rhythms.This could revolutionize stroke treatments and patient outcomes. dr. S. Thomas Carmichael envisions a future where medication helps patients achieve the same benefits as intensive rehab, a shift potentially transforming rehabilitation methods. while human trials await, this advancement offers a beacon of hope. Explore the possibilities.See what’s next for News Directory 3.
Drug Shows Promise for Stroke Recovery, Mimicking Rehab Effects
Updated June 06, 2025
A UCLA Health study has pinpointed a drug that mirrors the benefits of physical stroke rehabilitation in mice, offering hope for improved stroke recovery. Researchers say the drug, known as DDL-920, could revolutionize how stroke patients regain movement control.
The findings, published in Nature Communications, highlight the potential of DDL-920, one of two candidate drugs tested, to substantially improve motor skills following a stroke. stroke remains a primary cause of long-term disability, largely as most patients don’t fully recover, and effective drug therapies are lacking.
Dr.S. Thomas Carmichael, the study’s lead author and UCLA Neurology professor, envisions a future where stroke patients can take medication to achieve the same results as intensive rehabilitation. “Rehabilitation after stroke is limited as most patients cannot sustain the rehab intensity needed,” Carmichael said.
The research team investigated how physical rehabilitation enhances brain function post-stroke, aiming to develop a drug that replicates these effects. they discovered that stroke disrupts brain connections distant from the immediate damage site, impacting neural networks crucial for movement.
Specifically, the team found that stroke diminishes gamma oscillations, brain rhythms essential for coordinating neural networks. Successful rehabilitation, however, restores these oscillations and repairs damaged connections in parvalbumin neurons, a type of brain cell critical for movement.
DDL-920, developed in Dr. Varghese John’s UCLA lab, was identified as a potential drug to stimulate gamma oscillations. Testing showed it significantly improved movement control in the mouse model.
“The goal is to have a medicine that stroke patients can take that produces the effects of rehabilitation,” said Dr. S. Thomas Carmichael, the study’s lead author.
What’s next
While these findings are promising for stroke recovery and secondary_keyword_1,further research is essential to confirm the drug’s safety and effectiveness before human trials can begin. This research offers a new avenue for stroke treatment and secondary_keyword_2, potentially transforming rehabilitation and improving patient outcomes with a new stroke recovery drug.